Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 177

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 177
---
generally review market data, which is comprised of proxy-disclosed data from peer companies and information from nationally recognized
published surveys for the biopharmaceutical industry, adjusted for size. The market data helps the committee gain perspective on the compensation
levels and practices at the peer companies and to assess the relative competitiveness of the compensation paid to our executives. The
market data thus guides us in its efforts to set executive compensation levels and program targets at competitive levels for comparable
roles in the marketplace. We then consider other factors, such as the importance of each executive officer’s role to the Company,
individual expertise, experience, performance, retention concerns and relevant compensation trends in the marketplace, in making its final
compensation determinations.

Elements of Compensation

In addition to each officer’s base salary,
our executive officer compensation program consists of a cash incentive bonus plan and discretionary stock option awards in addition to
customary benefits. The amounts of compensation awarded for each element of the Company’s compensation program (i.e., base
salary, bonuses and stock options) are reviewed in connection with the Company’s performance.

Base Salary

Annual base salaries compensate our executive
officers for fulfilling the requirements of their respective positions and provide them with a level of cash income predictability and
stability with respect to a portion of their total compensation. We believe that the level of an executive officer’s base salary
should reflect the executive’s performance, experience and breadth of responsibilities, our understanding of salaries for similar
positions within our industry and any other factors relevant to that particular job.

Base salaries are typically negotiated at the
outset of an executive’s employment. Salary levels are considered annually as part of our performance review process, but also in
cases including promotion or other changes in the job responsibilities of an executive officer. For named executive officers, initial
base salaries generally are established in connection with negotiation of an offer of employment and employment agreement. Increases in
base salary have several elements. In addition to promotion and increased responsibilities, merit and Company-wide general increases are
also taken into consideration.

<div align='center'>110</div>

Stock-Based Awards

Historically, we have generally granted stock
options to our employees, including our named executive officers, in connection with their initial employment with us. We also have historically
granted stock options on an annual basis as part of annual performance reviews of our employees.

Our equity award program under the 2021 Plan,
as amended, is the primary vehicle for offering long-term incentives to our executives. We do not have